Should the guidelines for monitoring serum cholesterol levels in the elderly be re-evaluated?
Document Type
Article
Abstract
Elevated circulating cholesterol can have profound effects on the health of an individual. Such excess cholesterol can promote coronary artery disease, production and accumulation of β-amyloid in the brain, and possibly Alzheimer's disease (AD). In a clinical trial evaluating the benefit of a cholesterol-lowering drug in the treatment of AD, mean cholesterol levels at baseline among individuals participating in the trial were found to be relatively high. Based on this observation we suggest that cholesterol levels should be actively monitored in the elderly, as many individuals with AD are over 65 years of age and therefore excluded by currently accepted guidelines.
Publication Date
1-1-2002
Publication Title
Journal of Molecular Neuroscience
ISSN
08958696
Volume
19
Issue
1-2
First Page
209
Last Page
212
PubMed ID
12212783
Digital Object Identifier (DOI)
10.1007/s12031-002-0035-1
Recommended Citation
Sparks, D. L.; Connor, D. J.; Browne, P.; and Sabbagh, M. N., "Should the guidelines for monitoring serum cholesterol levels in the elderly be re-evaluated?" (2002). Neurology. 1030.
https://scholar.barrowneuro.org/neurology/1030